Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
43.23
-0.82 (-1.86%)
Nov 12, 2024, 3:59 PM EST - Market closed
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$329,508
Profits / Employee
$15,574
Market Cap
9.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,967 | -211 | -3.42% |
Dec 31, 2022 | 6,178 | 150 | 2.49% |
Dec 31, 2021 | 6,028 | 418 | 7.45% |
Dec 31, 2020 | 5,610 | 514 | 10.09% |
Dec 31, 2019 | 5,096 | 144 | 2.91% |
Dec 31, 2018 | 4,952 | 264 | 5.63% |
Dec 31, 2017 | 4,688 | 4 | 0.09% |
Dec 31, 2016 | 4,684 | 125 | 2.74% |
Dec 31, 2015 | 4,559 | 220 | 5.07% |
Dec 31, 2014 | 4,339 | 324 | 8.07% |
Dec 31, 2013 | 4,015 | 16 | 0.40% |
Dec 31, 2012 | 3,999 | 61 | 1.55% |
Dec 31, 2011 | 3,938 | 351 | 9.79% |
Dec 31, 2010 | 3,587 | 92 | 2.63% |
Dec 31, 2009 | 3,495 | 454 | 14.93% |
Dec 31, 2008 | 3,041 | 379 | 14.24% |
Dec 31, 2007 | 2,662 | 708 | 36.23% |
Dec 31, 2006 | 1,954 | 365 | 22.97% |
Dec 31, 2005 | 1,589 | 267 | 20.20% |
Dec 31, 2004 | 1,322 | -231 | -14.87% |
Dec 31, 2003 | 1,553 | -98 | -5.94% |
Dec 31, 2002 | 1,651 | 94 | 6.04% |
Dec 31, 2001 | 1,557 | 242 | 18.40% |
Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Teleflex | 14,500 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Exact Sciences | 6,600 |
Penumbra | 4,200 |
HealthEquity | 3,150 |
Exelixis | 1,310 |
QGEN News
- 5 days ago - Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
- 8 days ago - QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewsWire
- 14 days ago - QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewsWire
- 4 weeks ago - QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications - GlobeNewsWire
- 4 weeks ago - QIAGEN N.V. to release results for Q3 2024 and hold webcast - GlobeNewsWire
- 5 weeks ago - Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer - GlobeNewsWire
- 6 weeks ago - QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology - GlobeNewsWire